Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

The document suggests a young mother use effective contraception like the Copper-T IUD while considering her health and the need for STD prevention.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

SHBG may be a useful early indicator and treatment target for PCOS.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Finasteride causes lasting fertility decrease in rats.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Gut microbes significantly affect brain steroid levels.

Diet changes hormone levels in pregnant ewes by affecting metabolism, not placental synthesis.

Testosterone reduces key molecules needed for early pregnancy in rats.

Toxoplasma gondii infection may increase testosterone levels in males.

Melatonin may help manage PCOS by improving insulin sensitivity, hormone balance, and mood.